Open AccessSurvival in Patients with Glioblastoma Receiving Valganciclovir
Author(s) -
Cecilia SöderbergNauclér,
Afsar Rahbar,
Giuseppe Stragliotto
Publication year - 2013
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmc1302145
Subject(s) - medicine , glioblastoma , valganciclovir , retrospective cohort study , randomized controlled trial , oncology , overall survival , ganciclovir , surgery , human cytomegalovirus , immunology , virus , cancer research
A retrospective analysis of selected patients with glioblastoma who received treatment for cytomegalovirus with their anticancer treatment showed surprisingly good 2-year survival. A randomized trial is needed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom